IDXX Logo

IDEXX Laboratories, Inc. (IDXX) 

NASDAQ
Market Cap
$34.24B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
564 of 774
Rank in Industry
34 of 42

Largest Insider Buys in Sector

IDXX Stock Price History Chart

IDXX Stock Performance

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for …

Insider Activity of IDEXX Laboratories, Inc.

Over the last 12 months, insiders at IDEXX Laboratories, Inc. have bought $0 and sold $40.26M worth of IDEXX Laboratories, Inc. stock.

On average, over the past 5 years, insiders at IDEXX Laboratories, Inc. have bought $0 and sold $90.85M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 750 shares for transaction amount of $199,808 was made by Kingsley Lawrence D (director) on 2019‑08‑06.

List of Insider Buy and Sell Transactions, IDEXX Laboratories, Inc.

2024-09-06Saledirector
500
0.0006%
$469.37$234,686+0.41%
2024-05-17Saledirector
200
0.0002%
$540.80$108,160-10.94%
2024-03-06SaleExecutive Vice President
8,104
0.0098%
$558.44$4.53M-11.38%
2024-03-05Saledirector
1,404
0.0017%
$562.98$790,427-11.50%
2024-02-08SaleSVP, Chief Revenue Officer
8,198
0.0109%
$573.87$4.7M-13.36%
2024-02-07SalePresident and CEO
12,000
0.0159%
$572.61$6.87M-13.16%
2024-02-07SaleEVP, CFO and Treasurer
23,326
0.0307%
$570.01$13.3M-13.16%
2023-12-07SaleExecutive Vice President
11,636
0.014%
$521.79$6.07M-3.37%
2023-12-04SalePresident and CEO
7,128
0.0085%
$513.05$3.66M-1.73%
2023-08-31SalePresident and CEO
13,424
0.0162%
$512.01$6.87M-2.65%
2023-08-29SaleExecutive Vice President
22,909
0.0276%
$510.56$11.7M-2.48%
2023-08-15Saledirector
492
$0$0-1.93%
2023-08-03SaleExecutive Vice President
16,027
0.0194%
$510.00$8.17M-0.74%
2023-05-19Saledirector
10,000
0.0121%
$491.35$4.91M+3.10%
2023-05-18Saledirector
10,000
0.012%
$489.23$4.89M+2.26%
2023-05-05Saledirector
2,000
0.0023%
$474.89$949,789+1.95%
2023-05-05SaleExecutive Vice President
1,000
0.0012%
$484.00$484,000+1.95%
2023-05-04Saledirector
2,187
0.0026%
$469.02$1.03M+6.04%
2023-02-16SaleSenior Vice President
10
<0.0001%
$515.58$5,156-4.04%
2023-02-16Saledirector
2,187
0.0027%
$511.68$1.12M-4.04%

Insider Historical Profitability

17.17%
MCKEON BRIAN PEVP, CFO and Treasurer
29718
0.0363%
$418.20118+24.62%
Vandebroek Sophie V.director
1216
0.0015%
$418.2016+18.18%
Claflin Bruce L.director
161
0.0002%
$418.2024+4.5%
SZOSTAK M ANNEdirector
0
0%
$418.2049+20.21%
AYERS JONATHAN Wdirector
135547
0.1655%
$418.201124+36.54%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$4.97B11.159.21M+1.69%+$82.58M0.11
The Vanguard Group$4.58B10.268.48M+1.17%+$53.12M0.08
State Street$2.04B4.583.78M+0.1%+$1.96M0.08
AllianceBernstein$1.61B3.622.99M+1.79%+$28.42M0.57
Fundsmith LLP$1.47B3.292.71M-0.52%-$7.64M5.74
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.